Cargando…
Strain-Dependent Inhibition of Erythrocyte Invasion by Monoclonal Antibodies Against Plasmodium falciparum CyRPA
The highly conserved Plasmodium falciparum cysteine-rich protective antigen (PfCyRPA) is a key target for next-generation vaccines against blood-stage malaria. PfCyRPA constitute the core of a ternary complex, including the reticulocyte binding-like homologous protein 5 (PfRh5) and the Rh5-interacti...
Autores principales: | Knudsen, Anne S., Björnsson, Kasper H., Bassi, Maria R., Walker, Melanie R., Kok, Andreas, Cristinoi, Bogdan, Jensen, Anja R., Barfod, Lea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383283/ https://www.ncbi.nlm.nih.gov/pubmed/34447381 http://dx.doi.org/10.3389/fimmu.2021.716305 |
Ejemplares similares
-
Structural basis for inhibition of erythrocyte invasion by antibodies to Plasmodium falciparum protein CyRPA
por: Chen, Lin, et al.
Publicado: (2017) -
Generation of Plasmodium falciparum parasite-inhibitory antibodies by immunization with recombinantly-expressed CyRPA
por: Favuzza, Paola, et al.
Publicado: (2016) -
Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes
por: Healer, Julie, et al.
Publicado: (2019) -
Expanding the Malaria Antibody Toolkit: Development and Characterisation of Plasmodium falciparum RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies
por: Nacer, Adéla, et al.
Publicado: (2022) -
Vaccination with virosomally formulated recombinant CyRPA elicits protective antibodies against Plasmodium falciparum parasites in preclinical in vitro and in vivo models
por: Tamborrini, Marco, et al.
Publicado: (2020)